Prevention of bone loss with alendronate in kidney transplant recipients [4]

Transplantation

Volumn 70, Issue 10, 2000, Pages 1542-1543

  Kovač, Damjan ^a   Lindič, Jelka ^a   Kandus, Aljoša ^a   Bren, Andrej F ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCITRIOL; CALCIUM CARBONATE;

ADULT; BONE ATROPHY; BONE DENSITY; CLINICAL ARTICLE; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; LETTER; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034722682     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200011270-00028     Document Type: Letter

References (5)

1. Rapid loss of vertebral mineral density after renal transplantation
2. Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients
3. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced osteoporosis intervention study group
4. Pamidronate therapy as prevention of bone loss following renal transplantation
5. Treatment of osteopenia and osteoporosis after kidney transplantation